STOCK TITAN

[SCHEDULE 13G/A] Bluejay Diagnostics, Inc. Amended Passive Investment Disclosure

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Bluejay Diagnostics, Inc. had a Schedule 13G/A filing showing Armistice Capital, LLC and Steven Boyd reported beneficial ownership of 51,061 shares, representing 4.99% of the company's common stock (as of 03/31/2026). Armistice Capital, as investment manager to Armistice Capital Master Fund Ltd., reports shared voting and dispositive power over these shares; the Master Fund is the direct holder. Steven Boyd is identified as the managing member of Armistice Capital and is included in the joint filing.

Positive

  • None.

Negative

  • None.

Insights

Armistice Capital reports a sub-5% passive stake in Bluejay Diagnostics.

Armistice Capital and Steven Boyd disclosed beneficial ownership of 51,061 shares (4.99%) as of 03/31/2026, with shared voting and dispositive power via the investment manager relationship. The Master Fund is the direct holder; Armistice acts under an Investment Management Agreement.

Filing characterizes the position as ownership of 5% or less and includes a joint filing statement. Subsequent disclosures would be filed jointly if ownership changes.






095633608

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Armistice Capital, LLC
Signature:/s/ Steven Boyd
Name/Title:Steven Boyd - Managing Member
Date:05/15/2026
Steven Boyd
Signature:/s/ Steven Boyd
Name/Title:Steven Boyd
Date:05/15/2026
Exhibit Information

JOINT FILING STATEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Schedule 13G, is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G, shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate. Dated: May 15, 2026 Armistice Capital, LLC By: /s/ Steven Boyd Steven Boyd - Managing Member Steven Boyd By: /s/ Steven Boyd